Brought to you by WBIW News and Network Indiana
Last updated on Thursday, May 3, 2007
(WEST LAFAYETTE) - The Purdue Research Foundation is licensing new technology to a San Diego company that could be mass-produced into a bird flu vaccine.
The vaccine technology transports an extra gene related to the influenza virus. The extra gene produces a protein in the host's cells and triggers an immune response against bird flu.
The process still needs approval from the food and drug administration.
© Ad-Venture Media, Inc. All Rights Reserved.
Click here to go back to previous page